会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 13. 发明授权
    • Spirochromanone carboxylic acids
    • 新型螺环酮羧酸
    • US08524730B2
    • 2013-09-03
    • US12997263
    • 2009-06-29
    • Hideki JonaYoshihiro ShibataTakeru Yamakawa
    • Hideki JonaYoshihiro ShibataTakeru Yamakawa
    • C07D405/04A61K31/438
    • C07D491/107A61K31/438A61K31/444A61K31/4545A61K31/4709
    • The invention relates to a compound of a general formula (I): wherein A represents a linking group; Ar1 represents a group formed from an aromatic ring; R1 and R2 each independently represent a hydrogen atom, a halogen atom, a cyano group, a C2-C6 alkenyl group, a C1-C6 alkoxy group, a halo-C1-C6 alkoxy group, a cyclo-C3-C6 alkyloxy group, a C2-C7 alkanoyl group, a halo-C2-C7 alkanoyl group, a C2-C7 alkoxycarbonyl group, a halo-C2-C7 alkoxycarbonyl group, a cyclo-C3-C6 alkyloxycarbonyl group, an aralkyloxycarbonyl group, a carbamoyl-C1-C6 alkoxy group, a carboxy-C2-C6 alkenyl group, or a group of -Q1-N(Ra)-Q2-Rb; a C1-C6 alkyl group optionally having substituent(s); an aryl or heterocyclic group optionally having substituent(s); or a C1-C6 alkyl group or a C2-C6 alkenyl group having the aryl or heterocyclic group; T and U each independently represent a nitrogen atom or a methine group; and V represents an oxygen atom, a sulfur atom or an imino group. The compound of the invention is useful as therapeutical agents for various ACC-related diseases.
    • 本发明涉及通式(I)的化合物:其中A表示连接基团; Ar 1表示由芳香环形成的基团; R 1和R 2各自独立地表示氢原子,卤素原子,氰基,C 2 -C 6烯基,C 1 -C 6烷氧基,卤代-C 1 -C 6烷氧基,环-C 3 -C 6烷氧基, C2-C7烷酰基,卤代-C2-C7烷酰基,C2-C7烷氧基羰基,卤代-C2-C7烷氧基羰基,环-C3-C6烷氧基羰基,芳烷氧基羰基,氨基甲酰基C1- C6烷氧基,羧基-C2-C6烯基或-Q1-N(Ra)-Q2-Rb的基团; 任选具有取代基的C1-C6烷基; 任选具有取代基的芳基或杂环基; 或具有芳基或杂环基的C 1 -C 6烷基或C 2 -C 6烯基; T和U各自独立地表示氮原子或次甲基; V表示氧原子,硫原子或亚氨基。 本发明的化合物可用作各种ACC相关疾病的治疗剂。
    • 14. 发明申请
    • NOVEL SPIROCHROMANONE CARBOXYLIC ACIDS
    • 新型螺环酮羧酸
    • US20110077262A1
    • 2011-03-31
    • US12997263
    • 2009-06-29
    • Hideki JonaYoshihiro ShibataTakeru Yamakawa
    • Hideki JonaYoshihiro ShibataTakeru Yamakawa
    • A61K31/438C07D491/107A61P3/00A61P3/04A61P3/10A61P31/00
    • C07D491/107A61K31/438A61K31/444A61K31/4545A61K31/4709
    • The invention relates to a compound of a general formula (I): wherein A represents a linking group; Ar1 represents a group formed from an aromatic ring; R1 and R2 each independently represent a hydrogen atom, a halogen atom, a cyano group, a C2-C6 alkenyl group, a C1-C6 alkoxy group, a halo-C1-C6 alkoxy group, a cyclo-C3-C6 alkyloxy group, a C2-C7 alkanoyl group, a halo-C2-C7 alkanoyl group, a C2-C7 alkoxycarbonyl group, a halo-C2-C7 alkoxycarbonyl group, a cyclo-C3-C6 alkyloxycarbonyl group, an aralkyloxycarbonyl group, a carbamoyl-C1-C6 alkoxy group, a carboxy-C2-C6 alkenyl group, or a group of -Q1-N(Ra)-Q2-Rb; a C1-C6 alkyl group optionally having substituent(s); an aryl or heterocyclic group optionally having substituent(s); or a C1-C6 alkyl group or a C2-C6 alkenyl group having the aryl or heterocyclic group; T and U each independently represent a nitrogen atom or a methine group; and V represents an oxygen atom, a sulfur atom or an imino group. The compound of the invention is useful as therapeutical agents for various ACC-related diseases.
    • 本发明涉及通式(I)的化合物:其中A表示连接基团; Ar 1表示由芳香环形成的基团; R 1和R 2各自独立地表示氢原子,卤素原子,氰基,C 2 -C 6烯基,C 1 -C 6烷氧基,卤代-C 1 -C 6烷氧基,环-C 3 -C 6烷氧基, C2-C7烷酰基,卤代-C2-C7烷酰基,C2-C7烷氧基羰基,卤代-C2-C7烷氧基羰基,环-C3-C6烷氧基羰基,芳烷氧基羰基,氨基甲酰基C1- C6烷氧基,羧基-C2-C6烯基或-Q1-N(Ra)-Q2-Rb的基团; 任选具有取代基的C1-C6烷基; 任选具有取代基的芳基或杂环基; 或具有芳基或杂环基的C 1 -C 6烷基或C 2 -C 6烯基; T和U各自独立地表示氮原子或次甲基; V表示氧原子,硫原子或亚氨基。 本发明的化合物可用作各种ACC相关疾病的治疗剂。